Drug Approval | December 18, 2023
Zydus receives final approval from the USFDA for Lacosamide Tablets
Lacosamide is indicated to treat partial-onset seizures
Lacosamide is indicated to treat partial-onset seizures
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
The product will be manufactured at Lupin's Pithampur facility in India
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Receives registration of Valganciclovir powder for oral solution in Germany
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Expands patient reach to remotest towns by furthering investment in GoApptiv
Subscribe To Our Newsletter & Stay Updated
